Interaction of 14-3-3 proteins with the insulin-like growth factor I receptor (IGFIR): Evidence for a role of 14-3-3 proteins in IGFIR signaling

Biochemical and Biophysical Research Communications

Volumn 312, Issue 4, 2003, Pages 1060-1066

  Spence, Susan L ^a   Dey, Bhakta R ^a   Terry, Cheryl ^a   Albert, Paul ^a   Nissley, Peter ^a   Furlanetto, Richard W ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

14 3 3 proteins; Insulin receptor; Insulin like growth factor I receptor; PMA; Protein kinase C; Transformation; Yeast two hybrid

Indexed keywords

14 3 3BETA PROTEIN; AGAR; MUTANT PROTEIN; PHORBOL ESTER; PROTEIN; PROTEIN KINASE; SERINE DERIVATIVE; SOMATOMEDIN C RECEPTOR; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CATALYSIS; CELL STIMULATION; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

EID: 0344926379     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.043     Document Type: Article

References (26)

1. Ullrich A., Gray A., Tam A.W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E., Jacobs S., Francke U., Ramachandran J., Fujita-Yamaguchi Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:1986;2503-2512.
2. Nakae J., Kido Y., Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22:2001;818-835.
3. Louvi A., Accili D., Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev. Biol. 189:1997;33-48.
4. Accili D., Drago J., Lee E.J., Johnson M.D., Cool M.H., Salvatore P., Asico L.D., Jose P.A., Taylor S.I., Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:1996;106-109.
5. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:1993;59-72.
6. Lammers R., Gray A., Schlessinger J., Ullrich A. Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. EMBO J. 8:1989;1369-1375.
7. Cope D.L., Kalloo-Hosein H.E., Ursø B., Hayward A.C., Whitehead J.P., O'Rahilly S., Siddle K. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J. Biol. Chem. 274:1999;30864-30873.
8. Furlanetto R.W., Dey B.R., Lopaczynski W., Nissley S.P. 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor. Biochem. J. 327:1997;765-771.
9. Craparo A., Freund R., Gustafson A. 14-3-3 (ε) interacts with the insulin-like growth factor I receptor and insulin receptor substrate 1 in a phosphoserine-dependent manner. J. Biol. Chem. 272:1997;11663-11669.
10. Fu H., Subramanian R.R., Masters S.C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40:2000;617-647.
11. Tzivion G., Avruch J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 77:2002;3061-3064.
12. Dey B.R., Frick K., Lopaczynski W., Nissley S.P., Furlanetto R.W. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. Mol. Endocrinol. 10:1996;631-641.
13. Siebler T., Lopaczynski W., Terry C.L., Casella S.J., Munson P., DeLeon D.D., Phang L., Blakemore K.J., McEvoy R.C., Kelley R.I., Nissley P. Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15. J. Clin. Endocrinol. Metab. 80:1995;3447-3457.
14. Bouck N., di Mayorca G. Evaluation of chemical carcinogenicity by in vitro neoplastic transformation. Jakoby W.B., Pastan I.H. Methods in Enzymology. Vol. 58:1979;296-307 Academic Press, New York.
15. R.I. Geran, N.H. Greenberg, M.M. MacDonald, A.M. Schumacher, B.J. Abbott, Protocols for screening chemical agents and natural products against animal tumors and other biological systems (third edition), Cancer Chemother. Rep. (Part 3) 3 (1972) 51.
16. Pinheiro J.C., Bates D.M. Mixed-effects Models in S and S-plus. 2000;Springer, New York.
17. Wei L.J., Lin D.Y., Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J. Am. Stat. Assoc. 84:1989;1065-1073.
18. Kaleko M., Rutter W.J., Miller A.D. Overexpression of the human insulin-like growth factor-I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10:1990;464-473.
19. Lopaczynski W., Terry C., Nissley P. Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain. Biochem. Biophys. Res. Commun. 279:2000;955-960.
20. Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., Parker P.J. Protein kinase C isotypes controlled by phosphoinositide3-kinase through the protein kinase PDK1. Science. 281:1998;2042-2045.
21. Li W., Jiang Y.-X., Zhang J., Soon L., Flechner L., Kapoor V., Pierce J.H., Wang L.-H. Protein kinase C-δ is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol. Cell. Biol. 18:1998;5888-5898.
22. Xiao B., Smerdon S.J., Jones D.H., Dodson G.G., Soneji Y., Aitken A., Gamblin S.J. Structure of a 14-3-3 protein and implications for coordination of multiple signaling pathways. Nature. 376:1995;188-194.
23. Li S., Resnicoff M., Baserga R. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271:1996;12254-12260.
24. Hongo A., D'Ambrosio C., Miura M., Morrione A., Baserga R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene. 12:1996;1231-1238.
25. Peruzzi F., Prisco M., Morrione A., Valentis B., Baserga R. Anti-apoptotic signaling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-Raf and Nedd4. J. Biol. Chem. 276:2001;25990-25996.
26. Miura M., Surmacz E., Burgaud J.-L., Baserga R. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem. 270:1995;22639-22644.